Inactivated influenza vaccines

Perspectives in Medical Virology

Volumn 7, Issue , 2002, Pages 145-177

  Keitel, Wendy A ^a   Couch, Robert B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35449002957     PISSN: 01687069     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0168-7069(02)07008-8     Document Type: Article

References (151)

1. R. Couch J.A. Kasel W.P. Glezen H.R. Six L.H. Taber A.L. Frank Influenza: Its control in persons and populations J Infect Dis 153 3 1986 431 440
2. W.P. Glezen S.B. Greenberg R.L. Atmar P.A. Piedra R.B. Couch Impact of respiratory virus infections on persons with chronic underlying conditions JAMA 283 4 2000 499 505
3. R.B. Couch Influenza: Prospects for control Ann Intern Med 133 2 2000 992 998
4. CDC Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 50 2001 1 44 (RR-4)
5. K.M. Sullivan A.S. Monto I.M. Longini Estimates of the US health impact of influenza Am J Publ Health 83 1993 1712 1716
6. K.M. Edwards W.D. Dupont M.K. Westrich W.D. Plummer P.S. Palmer P.F. Wright A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease J Infect Dis 169 1994 68 76
7. K.M. Neuzil P.F. Wright E.F. Mitchell M.R. Griffin Burden of influenza illness in children with asthma and other chronic medical conditions J Pediatr 137 2000 856 864
8. C.H. Andrewes W. Smith Influenza: Further experiments on the active immunisation of mice Br J Exp Path 18 1937 43
9. F.M. Burnet Influenza virus infections of the chick embryo by the amniotic route: I. General character of infections Aust J Exp Biol Med 18 1940 353 360
10. T. Francis J.E. Salk H.E. Pearson P.N. Brown Protective effect of vaccination against induced influenza A J Clin Invest 24 1945 536 546
11. J.E. Salk W.J. Menke T. Francis A clinical, epidemiological, and immunological evaluation of vaccination against epidemic influenza Am J Hyg 42 1945 57 93
12. F.M. Davenport Control of influenza, symposium on influenza Med J Aust (Suppl) 1 1973 33 38
13. G. Meiklejohn Viral respiratory disease at Lowry Air Force Base in Denver, 1952–1982 J Infect Dis 148 1983 775 784
14. F.A. Ennis R.E. Mayner D.W. Barry J.E. Manischewitz R.C. Donlop M.W. Verbonitz Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines J Infect Dis 136 1977 S397 S406 (Suppl)
15. G.A. Poland The role of sodium bisulfite in the 1996–1997 USA influenza vaccine recall Vaccine 16 19 1998 1865 1868
16. K.L. Nichol K.L. Margolis A. Lind M. Murdoch R. McFadden M. Hauge Side effects associated with influenza vaccination in healthy working adults Arch Intern Med 156 1996 1546 1550
17. K.L. Margolis K.L. Nichol G.A. Poland R.E. Pluhar Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial JAMA 264 9 1990 1139 1141
18. A.S. Khan F. Polezhaev R. Vasiljeva V. Drinevsky J. Buffington H. Gary Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren J Infect Dis 173 1996 453 456
19. K.R. Murphy R.C. Strunk Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins Pediatr 106 6 1985 931 933
20. J.M. James R.S. Zeiger M.R. Lester M.B. Fasano J.E. Gern L.E. Mansfield Safe administration of influenza vaccine to patients with egg allergy J Pediatr 133 5 1998 624 628
21. A.H. Ropper M. Victor Influenza Vaccination and the Guillain-Barre Syndrome N Engl J Med 339 25 1998 1845 1846
22. L.B. Schonberger D.J. Bergman J.Z. Sulliban-Bolyai Guillain Barre Syndrome following vaccination in the National Influenza Immunization Program: United States, 1976–1977 Am J Epidemiol 110 1979 105 123
23. T. Lasky G.J. Terracciano L. Magder C.L. Koski M. Ballesteros D. Nash The Guillain-Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines N Engl J Med 339 25 1998 1797 1802
24. H. Saito T. Yanagisawa Acute cerebellar ataxia after influenza vaccination with recurrence and marked cerebellar atrophy Tohoku J Exp Med 158 1989 95 103
25. A.E. Miller L.A. Morgante L.Y. BuchWald S.M. Nutile P.K. Coyle L.B. Krupp A multicenter, randomized, double blind, placebo-controlled trial of influenza immunization in multiple sclerosis Neurology 48 1997 312 314
26. W.P. Glezen Maternal immunization for the prevention of infections in late pregnancy and early infancy Infect Med 16 1999 585 595
27. B.H.J. Stenius-Aarniala R. Pyhala T. Haahtela P. Jokela A. Jukkara T. Karakorpi Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus Chest 6 1989 786 789
28. P. Kramarz F. DeStefano P.M. Gargiullo R.L. Davis R.T. Chen J.P. Mullooly Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team Arch Fam Med 7 2000 617 623 (July 9)
29. K.G. Nicholson J.S. Nguyen-Van-Tam A.H. Ahmed M.J. Wiselka J. Leese J. Ayres Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma Lancet 351 1998 326 331 (January 31)
30. P. Kramer C.J. McClain Depression of aminopyrine metabolism by influenza vaccination N Engl J Med 305 21 1981 1262 1264
31. N Grabowski J.S. Bertino J.H. May D.S. Pratt W.J. Richtsmeier The effect of split virus influenza vaccination on theophyline pharmacokinetics: Concise clinical study Am Rev Respir Dis 131 1985 934 938
32. G. Raj R. Kumar W.P. McKinney Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy Arch Intern Med 155 1995 1529 1531
33. G.W. Williams A.D. Steinberg J.L. Reinertsen L.W. Klassen J.L. Decker R. Dolin Influenza immunization in systemic lupus erythematosus: A double blind trial Ann Intern Med 88 1978 729 734
34. R. Mader A. Narendran J. Lewtas V. Bykerk R.C.J. Goodman J.R. Dickson Systemic vasculitis following influenza vaccination-Report of 3 cases and literature review J Rheumatology 20 8 1993 1429 1431
35. P. Blanche C. Decrette D. Sicard Development of uveitis following vaccination for influenza Clin Infect Dis 19 1994 979
36. G.L. Miller W.M. Stanley Quantitative aspects of the red blood cell agglutination test for influenza virus J Exp Med 79 1944 185 195
37. D.W. Barry R.E. Mayner E. Staton R.C. Dunlap S.C. Rastogi J.E. Hannah Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man Am J Epidemiol 104 1976 34 45
38. LaMontagne Jr G.R. Nobel G. Quinnan G.T. Curlin W.C. Blackwelder J.I. Smith Summary of clinical trials of inactivated influenza vaccine-1978 Rev Infect Dis 5 1983 723 736
39. G.K. Hirst The agglutination of red cells by allantoic fluid in chick embryos infected with influenza virus Science 94 1941 22 23
40. W.E.P. Beyer I.A. deBruijn A.M. Palache R.G.J. Westendorp A.D.M.E. Osterhaus Protection against influenza after annually repeated vaccination Arch Intern Med 159 1999 182 188
41. A. Kendal T.R. Cate Increased sensitivity and reduced specificity of hemagglutinationinhibition tests with ether-treated influenza B/Singapore/222/79 J Clin Microbiol 18 1983 930 934
42. P.V. Knight R. Couch R.G. Douglas N.M. Tauraso Serologic response and natural infectious challenge of recipients of zonal ultracentrifuged influenza A/Aichi/2/68 Bull WHO 45 1971 761 771
43. M.L. Clements B.R. Murphy Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A vaccine J Clin Microbiol 23 1986 66 72
44. M.H. Snyder S. Banks B.R. Murphy Determination of antibody response to influenza virus surface glycoproteins by kinetic enzyme-linked immunosorbent assay J Clin Microbiol 26 1988 2034 2040
45. R.B. Couch R.G. Douglas D.S. Fedson J.A. Kasel Correlated studies of a recombinant influenza virus vaccine III. Protection against experimental influenza in man J Infect Dis 124 1971 473 480
46. W.A. Keitel R.B. Couch T.R. Cate K.R. Hess B. Baxter J.M. Quarles High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal antibody responses in healthy adults J Clin Microbiol 32 1994 2468 2473
47. H.Y. Reynolds W.M. Merrill E.P. Amento G.P. Naegel Immunoglobulin A in secretions from the lower respiratory tract J.R. McGhee J. Mestecky J.L. Babb Secretory Immunity and Infection 1978 Plenum Press New York 553 564
48. A.P. Kendal F.M. Bozeman F.A. Ennis Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations Infect Immun 29 1980 966 971
49. K.A. Brokstad R.J. Cox J. Olofsson R. Jonsson L.R. Haaeim Parental influenza vaccination induces a rapid systemic and local immune response J Infect Dis 171 1995 198 203
50. P.D. Parkman H.E. Hopps S.C. Rastogi H.H. Meyer Jr Summary of clinical trials of influenza virus vaccines in adults J Infect Dis 136 1977 5722 5730 (Suppl)
51. R.G. Webster J.A. Kasel R.B. Couch W.G. Laver Influenza subunit vaccines. II. Immunogenicity and original antigenic in humans J Infect Dis 134 1976 48 58
52. J.S. Oxford G.C. Schild The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection J Hyg 82 1979 51 61
53. F.A. Ennis A.H. Rook Q.Y. Hua G.C. Schild O. Riley R. Pratt HLA-restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines Lancet ii 1981 887 891
54. D.C. Powers R.B. Belshe Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine J Infect Dis 167 1993 584 592
55. F.M. Gotch A.J. McMichael G.L. Smith B. Moss Identification of the virus molecules recognized by influenza-specific cytotoxic T lymphocytes J Exp Med 165 1987 408 416
56. A.V. Hennessy F.M. Davenport Studies on vaccination of infants against influenza with influenza hemagglutinin Proc Soc Exp Biol Med 146 1974 200 204
57. T.R. Cate R. Couch R.A. Parker B.D. Baxter Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines-1978 Rev Infect Dis 5 1983 737 747
58. P.F. Wright J.D. Cherry H.M. Foy W.P. Glezen C.B. Hall K. McIntosh Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children—A multicentered evaluation of dosage and safety Rev Infect Dis 5 1983 758 764
59. R.A. Miller The aging immune system: primer and prospectus Science 273 1996 70 74
60. M. Saurwein-Tessl M.M. Steger S. Cryz B. Grubeck-Lobenstein Influenza vaccination in a healthy geriatric population: preferential induction of antibodies specific for H3N2 influenza strain despite equal T cell responsiveness to all vaccine strains Vaccine 16 2/3 1998 196 200
61. R.C. Pabico R.G. Douglas R.F. Betts B.A. McKenna R.B. Freeman Influenza vaccination of patients with glomerular diseases: Effects of creatinine clearance, urinary protein excretion, and antibody response Ann Intern Med 81 1974 171 177
62. + lymphocytes AIDS 8 1994 469 476
63. W. Lo E. Whimbey L. Elting R. Couch F. Cabanillas G. Bodey Antibody response to a two dose influenza vaccine regimen in adult lymphoma patients on chemotherapy European J Clin Micro Infect Dis 12 1993 778 782
64. N.M. Soesman G.F. Rimmelzwaan N.J. Nieuwkoop W.E. Beyer H.W. Tilanus M.H. Kemmeren Efficacy of influenza vaccination in adult liver transplant recipients J Med Virol 61 2000 85 93
65. W.T. Stille R.L. Woolridge B.F. Gundlefinger Antibody response to intracutaneous and subcutaneous influenza vaccination J Lab Clin Med 53 1959 751 754
66. R.B. Couch W.A. Keitel T.R. Cate J.M. Quarles L.H. Taber W.P. Glezen Prevention of Influenza Virus Infections by Current Inactivated Influenza Virus Vaccines L.E. Brown A.W. Hampson R.G. Webster Options for Control of Influenza III 1996 97 106
67. S. Weingarten H. Staniloff M. Ault P. Miles M. Bamberger R.D. Meyer Do hospital employees benefit from the influenza vaccine: A placebo controlled clinical trial Gen Intern Med 3 1988 32 37
68. K.L. Nichol A. Lind K.L. Margolis M. Murdoch R. McFadden M Hauge The effectiveness of vaccination against influenza in healthy, working adults N Engl J Med 333 14 1995 889 893
69. W.A. Keitel T.R. Cate R.B. Couch L.L. Huggins K.R. Hess Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period Vaccine 15 10 1997 1114 1422
70. D. Campbell M. Rumley Cost-effectiveness of the influenza vaccine in a healthy, working-age population J Occup Environ Med 39 1997 408 414
71. J.A. Wilde J.A. McMillan J. Serwint J. Butta M.A. O'Riordan M. Steinhoff Effectiveness of influenza vaccine in health care professionals: A randomized trial JAM 281 10 1999 908 913
72. H. Saxen M. Virtanen Randomized placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers Pediatr Infect Dis 18 9 1999 779 783
73. S.A. Tasker J.J. Treanor W.B. Paxton M.R. Wallace Efficacy of influenza vaccination in HIV-infected persons a randomized, double-blind, placebo-controlled trial Ann Intern Med 131 1999 430 433
74. C.B. Bridges W.W. Thompson M.I. Meltzer G.R. Reeve W.J. Talamonti N.J. Cox Effectiveness and cost-benefit of influenza vaccination of healthy working adults JAMA 284 13 2000 1655 1701
75. P.A. Patriarca J.A. Weber R.A. Parker W.N. Hall A.P. Kendal D.J. Bregman Efficacy of influenza vaccine in nursing homes: Reduction in illness and complications during an influenza A (H3N2) epidemic JAM 253 8 1985 1136 1145
76. A.J. Saah R. Neufeld M. Rodstein J.R. La Montague W.C. Blackwelder P. Gross G. Quinnan R.A. Kaslow Influenza vaccine and pneumonia mortality in a nursing home population Arch Intern Med 146 1986 2353 2357
77. D.A. Foster A.N. Talsma A. Furumoto-Dawson S.E. Ohmit J.R. Marguilies N. Arden Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly Am J Epidemiol 136 1992 296 307
78. M.E. Govaert C.T.M.C.N. Thijis N. Masurel M.J.W. Sprenger G.J. Dinant J.A. Knottnerus The efficacy of influenza vaccination in elderly individuals: A randomized double-blind placebo controlled trial JAMA 272 21 1994 1661 1701
79. J.P. Mullooly M.D. Bennett M.C. Hornbrook W.H. Barker W.W. Williams P.A. Patriarca Influenza Vaccination Programs for Elderly Persons: Cost-effectiveness in a Health Maintenance Organization Ann Intern Med 121 1994 947 952
80. K.L. Nichol K.L. Margolis J. Wuorenma T. Von Sternberg The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community N Engl J Med 331 12 1994 778 784
81. A.E.H. Ahmed K.G. Nicholson J.S. Nguyen-Van Tam Reduction in mortality associated with influenza vaccine during 1989–1990 epidemic The Lancet 346 1995 591 595
82. K.L. Nichol J. Wuorenma T. Von Sternberg Benefits of influenza vaccination for low, intermediate, and high risk senior citizens Arch Intern Med 158 1998 1769 1776
83. K.L. Nichol L. Barkn A. Nelson Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease Ann Intern Med 130 5 1999 397 402
84. S.E. Ohmit N. Arden A.S. Monto Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic J Am Geriatr Soc 47 1999 165 171
85. W.C. Gruber L.H. Taber W.P. Glezen R.D. Clover D. Abell R. Demmler Live attenuated and inactivated influenza vaccine in school age children AJDC 144 1990 595 600 (May)
86. R.D. Clover S. Crawford W.P. Glezen L.H. Taber C.C. Matson R.B. Couch Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses J Infect Dis 163 1991 300 304
87. P.A. Piedra W.P. Glezen Influenza in children: Epidemiology, immunity, and vaccines Semin Pediatr Infect Dis 2 2 1991 140 146
88. T. Heikkinen O. Ruuskanen M. Waris T. Zeigler M. Arola P. Halonen Influenza vaccination in the prevention of acute otitis media in children AJDC 145 1991 445 448 (April)
89. D.A. Clements L. Langdon C. Bland E. Walter Influenza A vaccine decreases the incidence of otitis media in 6–30-month old children in day care Arch Pediatr Adolesc Med 149 1995 1113 1117
90. E.S. Hurwitz M. Haber A. Chang T. Shope S.T. Teo J.S. Giesick Studies of the 1996–1997 inactivated influenza vaccine among children attending day care: Immunologic response, protection against infection, and clinical effectiveness J Infect Dis 182 2000 1218 1221
91. E.S. Hurwitz M. Haber A. Chang T. Shope S.T. Teo M. Ginsberg Effectiveness of influenza vaccination of daycare children in reducing influenza-related morbidity among household contacts JAMA 284 2000 1677 1682
92. K.M. Neuzil W.D. Dupont P.F. Wright K.M. Edwards Efficacy of inactivated and cold-adapted vaccines against influenza A infection 1985 to 1990; the pediatric experience Pediatr Infect Dis J 20 2001 733 740
93. P.J. Drinka S. Gravenstein P. Krause M. Schilling B.A. Miller P. Shult Outbreaks of influenza A and B in a highly immunized nursing home population J Fam Pract 45 1997 509 514
94. H.M. Foy M.K. Cooney R. McMahan A/Hong Kong influenza immunity three years after immunization JAMA 226 1973 758 761
95. T.W. Hoskins J.R. Davies A.J. Smith C.L. Miller A. Allchin Assessment of inactivated influenza—A vaccine after three outbreaks of influenza-A at Christ's Hospital Lancet 1979 33 35 January 6
96. K.L. Nichol Cost benefit analysis of a strategy to vaccinate healthy working adults against influenza Arch Intern Med 161 2001 749 (March 12)
97. J. Potter D.J. Stott M.A. Roberts A.G. Elder B. O'Donnell P.V. Knight Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients J Infect Dis 175 1997 1 6
98. W.F. Carman A.G. Elder L.A. Wallace K. McAulay A. Walker G.D. Murray Effects of influenza vaccination of health care workers on mortality of elderly people in long-term care: A randomised controlled trial Lancet 355 2000 93 97
99. V. Demicheli T. Jefferson D. Rivetti J. Deeks Prevention and early treatment of influenza in healthy adults Vaccine 18 2000 957 1030
100. C.H.L. Howells C.K. Vesselinova-Jenkins A.D. Evans J. James Influenza vaccination and mortality from bronchopneumonia in the elderly Lancet i 1975 381 383
101. W.H. Barker J.P. Mullooly Influenza vaccination in elderly persons JAMA 244 22 1980 2547 2549
102. P.A. Gross A.W. Hermogenes H.S. Sacks J. Lau R.A. Levandowski The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature Am College of Physicians 123 1995 518 527
103. K.M. Neuzil G.W. Reed E.F. Mitchell L. Simonsen M.R. Griffin Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women Am J Epidemiol 148 1998 1094 1102
104. J.A. Englund I. Mbawuike H. Hammill M.C. Holleman B.D. Baxter W.P. Glezen Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants J Infect Dis 168 1993 647 656
105. CDC Influenza and Pneumococcal Vaccination Levels Among Persons Aged ≥65 Years—United States, 1999 MMWR 50 25 2001 532 537
106. P.D.F. Kramarz P.M. Gargiullo R.L. Davis R.T. Chen J.P. Mullooly S.B. Black Influenza vaccination in children with asthma in health maintenance organizations Vaccine 18 2000 2288 2294
107. F. DeStefano R.A. Goodman G.R. Noble G.D. McClary S. Smith C.V. Broome Simultaneous administration of influenza and pneumococcal vaccines JAMA 247 18 1982 2551 2554
108. J.D. Grabenstein L.J. Smith D.W. Carter R.J. Engler R. Evans R.J. Summers Comprehensive immunization delivery in conjunction with influenza vaccination Arch Intern Med 146 1986 1189 1192
109. Adult Immunization Programs in Nontraditional Settings: Quality Standards and Guidance for Program Evaluation: A Report of the National Vaccine Advisory Committee; and Use of Standing Orders Programs to Increase Adult Vaccination Rates MMWR 49 1 2000 1 26
110. J.P. Mullooly Increasing influenza vaccination among high-risk elderly: A randomized controlled trial of a mail cue in an HMO setting Am J Publ Health 77 1987 626 627
111. K.G. Nicholson Immunisation against influenza among people aged over 65 living at home in Leicestershire during winter 1991-2 BMJ 306 1993 974 976
112. D.S. Fedson A. Wajda J.P. Nicol B. Comm L.L. Roos Disparity between Influenza Vaccination Rates and Risks for Influenza-associated Hospital Discharge and Death in Manitoba in 1982–1983 Ann Intern Med 116 1992 550 555
113. CDC Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000–2001 influenza season MMWR 49 27 2000 619 631
114. CDC Notice to readers: Delayed influenza vaccine availability for 2001–2002 season and supplemental recommendations of the Advisory Committee on Immunization Practices MMWR 50 2001 582 585
115. J. Treanor W. Keitel R. Belshe J. Campbell G. Schiff K. Zangwill M. Wolff A. Klimov R. Levandowski L. Lambert Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults Vaccine 20 2002 1099 1105
116. K.M. Neuzil B.G. Mellen P.F. Wright E.F. Mitchell M.R. Griffin The effect of influenza on hospitalizations, outpatients visits, and courses and antibiotics in children N Engl J Med 342 4 2000 225 239
117. A.S. Monto F.M. Davenport J.A. Napier T. Francis Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of school children J Infect Dis 122 1970 16 25
118. M.F. Warburton Herd immunity following subunit influenza vaccine administration Med J Austr 2 1972 67 70
119. T.A. Reichert N. Sugaya D.S. Fedson W.P. Glezen L. Simonsen M. Tashiro The Japanese experience with vaccinating school children against influenza N Engl J Med 344 12 2001 889 896
120. W.P. Glezen Emerging infections: Pandemic influenza Epidemiol Rev 18 1996 64 76
121. R. Couch J.A. Kasel H.R. Six T.R. Cate J.M. Zahradnik Immunological reactions and resistance to infection with influenza virus C.H. Stuart-Harris C.W. Potter The Molecular Virology and Epidemiology of Influenza: Beecham Colloquium on Aspects of Infection 1984 Academic Press London 119 153
122. W.R. Dowdle J.C. Downie W.G. Laver Inhibition of virus release by antibodies to surface antigens of influenza virus J Virol 13 1974 269 275
123. M.L. Clements S. O'Donnell M.M. Levine R.M. Chanock B.R. Mruphy Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody resistance to infection with vaccine virus Infect Immun 40 1983 1044 1051
124. E.D. Kilbourne B.E. Johansson Programmed antigenic stimulation—a new approach to influenza vaccination L.M. de la Maza E.M. Peterson Medical Virology 1991 Plenum Press New York 207 228
125. G.L. Ada K.N. Leung H. Ertl An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses Immunol Rev 58 1981 5 24
126. A.J. McMichael F.M. Gotch G.R. Nobel P.A. Beare Cytotoxic T-cell immunity to influenza N Engl J Med 309 1983 13 17
127. V.A. Slepushkin J.M. Katz R.A. Black W.C. Gamble P.A. Rota N.J. Cox Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein Vaccine 1995 1995 1399 1402
128. S.R. Mostow W.R. Dowdle S.C. Schoenbaum M.T. Coleman H.S. Kaye Inactivated vaccines. I. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation Postgrad Med J 49 1973 152 158
129. W. Keitel T.R. Cate R.L. Atmar C.S. Turner D. Nino C.M. Dukes Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly Clin Diag Lab Immunol 3 1996 507 510
130. R.F. Betts J.J. Treanor Approaches to improved influenza vaccination Vaccine 18 2000 1690 1695
131. E.D. Kilbourne R.B. Couch J.A. Kasel W.A. Keitel T.R. Cate J.M. Quarles Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans Vaccine 13 1995 1799 1803
132. F.M. Davenport Seventeen years' experience with mineral oil adjuvant influenza virus vaccines Ann Allergy 26 1968 288 292
133. R. Couch W. Keitel T.R. Cate Improvement of inactivated influenza virus vaccines J Infect Dis 176 1997 S38 344 (Supp 1)
134. S. DeDonato D. Granoff M. Minutello G. Lecchi M. Faccini M. Agnello Safety and immunogenicity of M1759-adjuvanted influenza vaccine in the elderly Vaccine 17 1999 3094 3101
135. S. Gravenstein E.H. Duthie B.A. Miller E. Roecker P.J. Drinka K. Prathipati Augmentation of influenza antibody response in elderly men by thymosin alpha 1 J Am Geriatr Soc 31 1989 1 18
136. M. Provinciali G. Di Stefano M. Colombo F.D. Croce M.C. Gandolfi L. Daghetta Adjuvant effect of low-dose interleukin-2 on antibody response to influenza virus vaccination in healthy elderly subjects Mech Aging Develop 77 1994 75 82
137. T.M. Moran H. Park A. Fernandez-Sesma J.L. Schulman Th2 responses to inactivated influenza virus can be converted to Thl responses and facilitate recovery from heterosubtypic virus infection J Infect Dis 180 1999 579 585
138. K.R. Beutner T. Chow E. Rubi J. Strussenberg J. Clement P.L. Ogra Evaluation of a neuraminidase-specific influenza A virus vaccine in children: Antibody responses and effects on two successive outbreaks in natural infection J Infect Dis 140 1979 844 850
139. F.M. Munoz G.J. Galasso J.M. Gwaltney Jr F.B. Hayden B.R. Murphy R.G. Webster Current research on influenza and other respiratory viruses: II 4th edn. International Symposium Antiviral Res. Antiviral Res 46 2000 91 124
140. G.L. Ada P.D. Jones The immune response to influenza infection Current Topics Micro Immunol 128 1986 1 54
141. L. Mbawuike J. Galarza D.F. Summers R.B. Couch A baculovirus-expressed influenza A/Udorn (H3N2) nucleoprotein induces protective T cell immunity against influenza A/H3N2 and A/H1N1 in mice Vaccine Res 3 1994 211 227
142. J.B. Ulmer J.J. Donnelly S.E. Parker G.H. Rhodes P.L. Felgner V.J. Dwarki Heterologous protection against influenza by injection of DNA encoding a viral protein Science 259 1993 1745
143. J.A. Kasel R.D. Rossen R.V. Fulk D.S. Fedson R.B. Couch P. Brown Human Influenza: Aspects the immune response to vaccination Ann Intern Med 71 1969 369 398
144. E.D. Kilbourne J.L. Schulman G. Schooler J. Swanson D. Bucher Correlated studies of a recombinant influenza virus vaccine. I. Derivation and characterization of the virus and vaccine J Infect Dis 124 1971 449 462
145. R. Glück A. Wegman Liposomal presentation of influenza antigens 4th edn. R.G. Webster A.D. Hay Textbook of Influenza 1998 Blackwell London, UK 400 409
146. P. Crovari E. Garbarino B. Bruzzone G. Herzog R. Glueck The efficacy of intranasal inactivated trivalent influenza vaccine in children and adults Options for the Control of Influenza IV 2000 23 28
147. F.W. Van Ginkel R.J. Jackson Y. Yuki J.R. McGhee Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins in olfactory tissues J Immunol 165 2000 4778 4782
148. O. Kistner P.N. Barrett W. Mundt M. Reiter S. Schober-Benedixin F. Dorner Development of a mammalian cell (Vero) derived candidate influenza virus vaccine Vaccine 16 1998 960 968
149. I.V. Aymova S. Kodihalli E.A. Govorkova B. Fanget C. Gerdil Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs J Virol 72 1998 4472 4477
150. D.S. Fedson Y. Hirota H.K. Shin C. Pierre-Etienne J. Kiely F. Ambrosch Influenza vaccination in 22 developed countries: an update to 1995 Vaccine 15 14 1997 1506
151. G.A. Poland T. Scott T. Rottinghaus R.M. Jacobsen Influenza vaccines: a review and rationale for use in developed and underdeveloped countries Vaccine 19 2001 2216 2220